Jingyan Yi
Impact in
-
- Ovarian cancer diagnosis and treatment
- Ovarian function and disorders
-
- PARP inhibition in cancer therapy
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
-
- Ovarian function and disorders 4
- Co-authors
- Jinshan Xing (10 shared papers)Pixu Liu (6 shared papers)Hailing Cheng (5 shared papers)Xin Luo (6 shared papers)Xiaolin Sang (4 shared papers)Zhiwei Tao (3 shared papers)Fuwen Luo (2 shared papers)Gan Qiao (7 shared papers)
In The Last Decade
Jingyan Yi
20 papers receiving 265 citations
Peers
Comparison fields: 5 of 60
- Reproductive Medicine 32
- Oncology 68
- Cancer Research 36
- Biological Psychiatry 5
- Endocrine and Autonomic Systems 10
Countries citing papers authored by Jingyan Yi
This map shows the geographic impact of Jingyan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyan Yi more than expected).
Fields of papers citing papers by Jingyan Yi
This network shows the impact of papers produced by Jingyan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyan Yi. The network helps show where Jingyan Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingyan Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 60 | |
| 2 | 2023 | 37 | |
| 3 | 2019 | 27 | |
| 4 | 2018 | 26 | |
| 5 | 2021 | 21 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 17 | |
| 8 | 2024 | 15 | |
| 9 | 2023 | 10 | |
| 10 | 2025 | 10 | |
| 11 | 2019 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2025 | 3 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2022 | 1 |
About Jingyan Yi
Jingyan Yi is a scholar working on Molecular Biology, Reproductive Medicine, Oncology, Epidemiology and Biomaterials, having authored 21 papers that have together received 267 indexed citations. Recurring topics across this work include Ovarian function and disorders (4 papers), Cancer-related Molecular Pathways (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Ubiquitin and proteasome pathways (1 paper), Protein Degradation and Inhibitors (1 paper), Liver physiology and pathology (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Reproductive Medicine (32 citations), Oncology (68 citations), Cancer Research (36 citations), Biological Psychiatry (5 citations) and Endocrine and Autonomic Systems (10 citations). Jingyan Yi has collaborated with scholars based in China and Israel. Frequent co-authors include Jinshan Xing, Pixu Liu, Hailing Cheng, Xin Luo, Xiaolin Sang, Zhiwei Tao, Fuwen Luo, Gan Qiao, Chunxiang Zhang and Shuang Liu. Their work appears in journals such as Cancer Letters, Clinical Science, Journal of Ovarian Research, Journal of Dermatological Science and Bioengineering & Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.